Home Medicine Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
Article
Licensed
Unlicensed Requires Authentication

Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism

  • Heide De Haene , Youri Taes , Armand Christophe and Joris Delanghe
Published/Copyright: September 21, 2011

Abstract

Background: In plasma, triglycerides (TG) are transported in lipoprotein particles (mainly chylomicrons, very low-density and low-density lipoprotein). Turbidimetry (bichromatically at 660 and 700nm) allows measurement of the lipemic (L) index. We explored the use of this index, in combination with a TG assay, to detect errors due to non-fasting, to assess abnormalities in TG metabolism and to detect patients with glycerol kinase deficiency (GKD).

Methods: We collected 2441 patient samples. Normolipidemic (n=2347), type IV hyperlipidemic (n=80), postprandial samples (n=22) and serial dilutions of Intralipid with saline (n=6) were selected. One patient presenting with GKD was included, as well as two patients with type I and type V hyperlipoproteinemia, respectively.

Results: We introduced the use of the ratio between the logarithm of serum triglycerides and that of the L-index (TG/L ratio).

Conclusion: Although the proposed TG/L-index ratio cannot be regarded as an alternative for the accurate diagnosis of lipid disorders, it provides additional information about TG-containing particles.


Corresponding author: Prof. Dr. Joris Delanghe, MD, PhD, Laboratory Clinical Chemistry 2P8, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium Phone: +32-9-2405405, Fax: +32-9-2404985,

References

1. Kwiterovich PO Jr. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 2000; 21:5L–10L.10.1016/S0002-9149(00)01461-2Search in Google Scholar

2. Karpe F, Hellenius ML, Hamsten A. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism 1999; 48:301–7.10.1016/S0026-0495(99)90076-8Search in Google Scholar

3. Fredrickson DS. Phenotyping. On reaching base camp (1950–1975). Circulation 1993; 87:III1–15.Search in Google Scholar

4. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3:213–29.Search in Google Scholar

5. Mahley RW, Rall SC Jr. Type III hyperlipidemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 2001:2835–63.Search in Google Scholar

6. Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002; 51:1949–56.10.2337/diabetes.51.6.1949Search in Google Scholar PubMed

7. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Wells A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18:1046–53.10.1161/01.ATV.18.7.1046Search in Google Scholar PubMed

8. Pozharski EV, McWilliams L, MacDonald RC. Relationship between turbidity of lipid vesicle suspensions and particle size. Anal Biochem 2001; 291:158–62.10.1006/abio.2001.5012Search in Google Scholar PubMed

9. Grafmeyer D, Bondon M, Manchon M, Levillain P. The influence of bilirubin, haemolysis and turbidity on 20 analytical tests performed on automatic analysers. Results of an interlaboratory study. Eur J Clin Chem Clin Biochem 1995; 33:31–52.Search in Google Scholar

10. Pearson JR, Wells R, Wells A. Serum index identifies lipemic samples causing interference with bilirubin assay on Hitachi 717. Clin Chem 1991; 37:2014–5.10.1093/clinchem/37.11.2014Search in Google Scholar

11. Sampson M, Ruddel M, Elin RJ. Effects of specimen turbidity and glycerol concentration on nine enzymatic methods for triglyceride determination. Clin Chem 1994; 40:221–6.10.1093/clinchem/40.2.221Search in Google Scholar

12. Walker AP, Muscatelli F, Stafford AN, Chelly J, Dahl N, Blomquist HK, et al. Mutations and phenotype in isolated glycerol kinase deficiency. Am J Hum Genet 1996; 58:1205–11.Search in Google Scholar

13. Wahlefeld AW, Bergmayer HU. Methods of enzymatic analysis 2. New York, NY: Academic Press, 1974:1831.10.1016/B978-0-12-091304-6.50036-7Search in Google Scholar

14. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6:67–75.10.3109/10715768909073429Search in Google Scholar PubMed

15. Brunzell JD, Deeb SS. Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill, 2001:2789–816.Search in Google Scholar

Received: 2005-8-2
Accepted: 2005-11-3
Published Online: 2011-9-21
Published in Print: 2006-2-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Allergy testing: the role of recombinant allergens
  2. Autoimmune diagnostics in diabetes mellitus
  3. Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
  4. Autoimmune bullous disorders
  5. Laboratory network of excellence: enhancing patient safety and service effectiveness
  6. Novel mutations in the 5′-UTR of the FOLR1 gene
  7. CYP2C8 polymorphism among the Portuguese
  8. Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
  9. Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
  10. Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
  11. Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
  12. Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
  13. Establishment of an indocyanine green test using an automatic chemistry analyzer
  14. Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
  15. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
  16. Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
  17. Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
  18. Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
  19. Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
  20. Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
  21. Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
  22. Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
Downloaded on 7.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.040/pdf
Scroll to top button